Bromo-DragonFLY

Bromo-DragonFLY
Clinical data
Other names	BDF; B-DFLY; DOB-DragonFLY; DOB-DFLY; 3C-Bromo-DragonFLY
Routes of; administration	Oral
Drug class	Serotonin 5-HT2 receptor agonist; Serotonin 5-HT2A receptor agonist; Serotonergic psychedelic; Hallucinogen; Monoamine oxidase inhibitor (MAOI); Reversible inhibitor of monoamine oxidase A (RIMA)
ATC code	None;
Legal status
Legal status	AU: Unscheduled; CA: Unscheduled; DE: Unscheduled; UK: Unscheduled; US: Unscheduled (Illegal in Oklahoma); UN: Unscheduled;
Pharmacokinetic data
Onset of action	Up to 6 hours
Duration of action	12–24 hours or up to 2–3 days
Identifiers
	IUPAC name 1-(4-bromofuro[2,3-f][1]benzofuran-8-yl)propan-2-amine;
CAS Number	219986-94-4;
PubChem CID	9839057;
ChemSpider	8014776 ;
UNII	GC9M7R36OI;
ChEMBL	ChEMBL149024 ;
Chemical and physical data
Formula	C13H12BrNO2
Molar mass	294.148 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC(N)Cc1c2ccoc2c(Br)c2ccoc12;
	InChI InChI=1S/C13H12BrNO2/c1-7(15)6-10-8-2-4-17-13(8)11(14)9-3-5-16-12(9)10/h2-5,7H,6,15H2,1H3 ; Key:GIKPTWKWYXCBEC-UHFFFAOYSA-N ;
	(verify)

Bromo-DragonFLY, also known as DOB-DragonFLY (DOB-DFLY), is a psychedelic drug of the phenethylamine, DOx, and FLY families. It is taken orally. The drug has a delayed onset of up to 6 hours and a very long duration of up to 1 to 3 days.

Side effects of Bromo-DragonFLY include nausea and vomiting, headache, tachycardia, hypertension, anxiety, panic attacks, pupil dilation, convulsions and vasoconstriction, among others. The drug acts as an agonist of the serotonin 5-HT₂ receptors, including the serotonin 5-HT_2A, 5-HT_2B, and 5-HT_2C receptors. It is also a potent monoamine oxidase A (MAO-A) inhibitor.

Bromo-DragonFLY was first described in the scientific literature by David E. Nichols and colleagues in 1998. It was encountered as a novel designer drug in 2006. The drug has been associated with an unusually high degree of toxicity and numerous hospitalizations and fatalities. It has become a controlled substance in various countries in the world.